Ascendis succeeds in buying time to settle debts
Lenders give the drug maker 18 months to tame a debt burden that is 10 times its market cap
08 June 2020 - 08:27
UPDATED 08 June 2020 - 17:52
Ascendis Health has pushed back payment on its debt facilities until the end of 2021, buying it an additional 18 months to sell off businesses to address a debt pile more than 10 times its market capitalisation.
The group’s lenders had been “extremely supportive” in giving Ascendis the space it needs to stabilise operations and prepare assets for sale at the right price, said CEO Mark Sardi. The group still intends to put Remedica up for sale later in 2020, but now has space to ensure its assets are ready for sale...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.